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INTRODUCTION:  Bleeding  related  to low-molecular-weight  heparins  (LMWHs)  is typically  described  as
an  excess  of  minor  bleeding;  however,  several  reports  of  spontaneous  major  bleeding  have  been noted.
PRESENTATION OF CASE:  A  58-year-old  female  presented  to the  hospital  with  bilateral  spontaneous  lower
extremity  hematomas  which  rapidly  enlarged.  CT studies  demonstrated  active  arterial  extravasation  fromeywords:
ow molecular weight heparin
emorrhage
ematoma
pontaneous
ower extremity
small  vessels  at  multiple  sites  within  each  leg with  no  dominant  feeding  artery  identiﬁed  on  either  side.
She  required  multiple  transfusions,  administration  of  protamine,  fresh  frozen  plasma  (FFP),  recombinant
activated  Factor  VII  and  eventual  surgery.
DISCUSSION: Dalteparin  provides  an  effective  and economical  method  of  anticoagulation,  however  there
is  a  risk of signiﬁcant,  spontaneous  arterial  hemorrhage  even  in  the  absence  of risk  factors.
CONCLUSION: Dalteparin  can  cause  major  spontaneous  bleeding  from  multiple  arterial  sources.
© 2013 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. . Introduction
Low-molecular-weight heparins (LMWHs) have become the
redominant choice as ﬁrst line agents for both the prophylaxis
f and treatment for deep venous thrombosis (DVT). These agents
re popular for inpatient and home administration because of the
ecreased need for laboratory monitoring, resulting in lower costs,
nd their limited interactions with other medications or foods.1
ther advantages of Dalteparin (Fragmin®, Pﬁzer inc., New York,
Y) are the simpliﬁed ﬁxed dosing and the improved safety in
atients with severe renal insufﬁciency, though it is not recom-
ended for those with severe liver or kidney disease.2
Dalteparin is comparable in safety and efﬁcacy to unfractionated
eparins and has a lower risk of heparin induced thrombocy-
openia. However, LMWHs have been shown to increase bleeding
omplications. In a study of 1873 patients given Dalteparin, 5.5%
f the patients experienced major bleeding and 0.7% had serious
dverse events.3 The occurrence of a bilateral spontaneous bleed
epresents a rare and serious complication of dalteparin.     
∗ Corresponding author at: USF Division of Plastic Surgery, 2 Tampa General Circle,
th ﬂoor, Tampa, FL 33606, USA. Tel.: +1 813 844 8783; fax: +1 813 844 1928.
E-mail address: jdagget1@health.usf.edu (J.R. Daggett).
210-2612 ©  2013 The Authors. Published by Elsevier Ltd on behalf of Surgical Associate
ttp://dx.doi.org/10.1016/j.ijscr.2013.07.0362. Discussion of case
A  58-year-old female with a remote history of a laryngeal
squamous cell carcinoma treated with a laryngopharyngectomy
reported to the rapid care unit with a complaint of bilateral lower
extremity swelling, blister formation and severe pain. The patient
reported that her symptoms began earlier in the morning after
having a bowel movement (BM). The patient stated that after stand-
ing up, she immediately noticed bruising on the medial aspect
of her right leg and the anterolateral aspect of her left leg. She
denied any signiﬁcant straining with her BM or preceding trauma.
Her vital signs were unremarkable: temperature of 37 ◦C, pulse of
75 beats/min, blood pressure of 118 mmHg/67 mmHg, and a respi-
ratory rate of 18 breaths/min.
The patient had recently been discharged from the hospital after
treatment for a polymicrobial bacteremia, during which she devel-
oped a three vessel upper extremity deep venous thrombosis (DVT)
at the site of her PICC line. At the time she was also noted to
have idiopathic transaminitis. Her discharge medications included
furosemide, piperacillin-tazobactam, micafungin, ranitidine, oxy-
butynin, levothyroxine, risperidone, oxycodone and dalteparin.
This was  her ﬁrst time receiving dalteparin injections. There was
no history of diabetes, cardiac, liver or kidney disease.
Initial examination revealed two large bullous lesions measur-
ing 14 cm × 8 cm on the right and 7 cm × 5 cm on the left. The lesions
and the distal extremities were very painful to palpation, however,
Open access under CC BY-NC-ND license. sensation was intact and 2+ palpable dorsalis pedis and posterior
tibial pulses were noted. The patient was admitted to intensive care
for hourly neurovascular checks, and the surgery team was  involved
for possible compartment syndrome. On further examination,
s Ltd. Open access under CC BY-NC-ND license. 
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over the following day. Of note, the drop in her platelets,
from 500,000/mcL to 256,000/mcL to 144,000/mcL, was  transient,
rebounding to 203,000/mcL on hospital day 4. On hospital day 4,
the results of the factor X activity returned with 57% activity. TheFig. 1. (A and B) Computed tomography images showing lower extre
ompartment syndrome was excluded, and the masses were felt
o likely be hematomas. Admission laboratory tests revealed ane-
ia  with a hemoglobin (Hgb) of 8.3 g/dL, a white blood cell count of
0.45 × 103/mcL and a platelet count of 418,000/mcL. Coagulation
tudies showed a PT of 12.6 s and a PTT of 43.5 s. Transaminases
ere mildly elevated with an AST of 73 U/L and ALT of 140 U/L.
ibrinogen was measured to be 343 mg/dL and the d-dimer was
ess than 0.5 mcg/L.
The patient was initially managed conservatively with compres-
ive dressings and elevation. However, within 3 h, the masses had
xpanded rapidly to 22 cm × 8.5 cm on the right and 12 cm × 8 cm
n the left. The overlying skin had become taut and the masses very
rm, though ballotable. Concern that this could represent arterial
leeding prompted a consult request to interventional radiology,
nd angiography and coiling were anticipated. However, a pre-
rocedural CT demonstrated an essentially unremarkable abdomen
nd pelvis with large ﬂuid collections affecting bilateral lower
xtremities consistent with hematomas. Active arterial extravasa-
ion from small vessels was noted at multiple sites within each leg,
lthough no dominant feeding artery was identiﬁed on either side
Fig. 1A and B) Given these ﬁndings, conservative management was
ontinued with one dose of protamine (150 mg)  given to potentially
ounteract dalteparin toxicity.
Throughout this time, the hematomas continued to increase in
ize (Fig. 2) with stable vital signs and serial neurovascular exam-
nation. However, 5 h after presentation, a repeat complete blood
ount (CBC) returned with a hemoglobin of 5.2 g/dL and platelets
f 405,000/mcL. Three units of packed red blood cells (pRBC) and 2
nits of FFP were transfused immediately. A post transfusion CBC
howed an appropriate hemoglobin response to 7.9 g/dL, platelets
f 256,000/mcL, a PT of 12.2 s and a PTT of 35.3 s. The hematomas
ontinued to enlarge and the following morning, 11 h after pre-
entation, the patient became tachycardic and hypotensive. Her
emoglobin had dropped again, to 5.7 g/dL. She was  given more IV
uids, an additional 2 units of pRBC and 2 units of FFP, but remained
ypotensive until she was started on a neosynepherine drip. She
as given a 90 mcg/kg dose of recombinant activated Factor VII.
er hemoglobin rose to 7.2 g/dL and her PT was 9.6 s and PTT 25.3 s.
he received an additional 2 units of pRBC and 2 units of FFP, result-
ng in a ﬁnal hemoglobin of 9.6 g/dL. Given the patient’s instability
nd failure to respond to medical management, the decision wasematomas with multiple points of arterial extravasation bilaterally.
made to take the patient to the operating room (OR) for incision
and drainage of bilateral lower extremities.
The patient did stabilize in the late morning prior to the pro-
cedure roughly 14 h after presentation and 25 h after the bruising
was ﬁrst noted. In the OR, exploration revealed massive hematomas
(Fig. 3) apparently arising from diffuse bleeding from the underly-
ing wound bed; no speciﬁc points of major bleeding were found.
Of note, the area where the patient’s hematoma initially began
appeared to be intradermal, as though within a bulla, however, as
it expanded, the hematoma had extended into the superﬁcial sub-
cutaneous space. Hemostasis was  achieved using a combination of
electrocautery, the Aquamantys system (Medtronic, Portsmouth,
NH) and topical thrombin. The skin ﬂaps were loosely closed over
drains and dressed with gauze bandage rolls and compressive elas-
tic bandage wraps. The patient was returned to the ICU where she
received an additional 3 units of pRBC, bringing the haaemoglobin
to 6.3 g/dL. An additional CBC that evening yielded a hemoglobin of
12.7 g/dL and platelets of 144,000/mcL (Fig. 4).
The patient remained stable and bleeding gradually resolvedFig. 2. Pre-operative image of bilateral lower extremity hematomas.
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ransaminitis resolved as well. The affected skin underwent necro-
is. On hospital day 9, the patient underwent split-thickness skin
rafting to her bilateral lower extremity wounds. She recovered
ell from this operation and was eventually discharged on hospital
ay 22.
. Discussion
Documented risk factors for LMWH-induced bleeding include:
dvanced age, concurrent medications such as aspirin, use of
igh doses, concomitant thrombocytopenia and impaired renal
unction.4 There have been several reported incidences of patients
eveloping spontaneous hematomas related to the use of LMWH  in
he absence of any trauma. These have ranged from retroperitoneal
ematomas to spontaneous splenic rupture.5–11 Several reports of
pontaneous unilateral lower extremity hematoma involved signif-
cantly older patients with one or more risk factors such as diabetes
r kidney disease.12–15 One of these studies also noted multiple
ites of arterial extravasation.12 However, this patient developed
ilateral, simultaneous arterial hemorrhage from multiple small
ig. 4. Immediate post-operative view following second surgery with split-
hickness skin grafting to areas of skin loss.PEN  ACCESS
gery Case Reports 4 (2013) 1080– 1083
vessels without any history of trauma. Additionally, this occurred in
a 58 year-old female on a ﬁxed dosing regimen without any known
underlying diabetes or kidney disease or thrombocytopenia. While
the patient did have a brief transaminitis prior to the event, this
resolved and she carries no diagnosis of liver disease.
Dalteparin is convenient in not requiring monitoring of labora-
tory values. However, the lack of an ability to effectively monitor
can prove to be a signiﬁcant detriment. Current management
of LMWH-induced hematoma formation includes administration
of protamine sulfate and FFP. However, as demonstrated here,
this does not always ensure a timely reversal and cessation of
bleeding. Resolution of this patient’s coagulopathy required Fac-
tor VII, a very costly therapy. Additionally, the signiﬁcance of the
patient’s progressive, though transient, thrombocytopenia is dif-
ﬁcult to determine in the setting of multiple transfusions and
aggressive volume resuscitation, but a delayed HIT response cannot
be excluded. Given the increasing number of reports of LMWH-
induced arterial bleeding from multiple small vessels, the difﬁculty
in effectively treating this situation, and the expanding use of
LMWHs  on the perioperative setting, the relative safety of LMWHs
compared to other therapies remains an area for future research.
4. Conclusion
This case demonstrates a unique and very serious bleeding
complication of dalteparin use. It demonstrates that signiﬁcant
uncontrolled bleeding from multiple separate sites can occur spon-
taneously despite a lack of trauma or signiﬁcant risk factors.
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